questions about the safety of Multaq (dronedarone) for atrial fibrillation

February 2011

Please see the July 2011 FDA warning concerning Multaq and an increased risk of serious adverse events

New concerns raise questions about the safety of Multaq (dronedarone) for atrial fibrillation.

This is especially important since the most recent guidelines recommend Multaq before amiodarone in many cases for A fib.

Multaq is less effective than amiodarone...but it SEEMED safer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Infectious Diseases New guidelines for treating methicillin-resistant S. aureus (MRSA) will change treatment of community-acquired skin infections
Cardiology questions about the safety of Multaq (dronedarone) for atrial fibrillation
Cardiology whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients
Respiratory & Allergy Daxas (DAX-is) for severe COPD in patients with chronic bronchitis
Renal & Urology New Canadian guidelines will help improve treatment of RECURRENT urinary tract infections (UTIs) in women
Psychiatry help getting a suitable atypical antipsychotic
Dermatology Protopic (tacrolimus ointment) will now be used to PREVENT flare-ups of atopic dermatitis
Hair Loss if their medications are causing hair loss
Vitamins & Minerals if vitamin E supplements are dangerous
Women's Health new oral contraceptive called Seasonique
Poison Prevention even small doses of some drugs can be toxic in young children
Opioids confusion about the various extended-release tramadol products